Li Zhang

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Li Zhang
Oct 27, 2024, 14:10 | Blog
Genomic Stability Thresholds and DPY30 as a Biomarker in Pancreatic Cancer
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…
Oct 11, 2024, 13:53 | Blog,Opinion
WRAD complex's impact on epigenetic regulation and immunoediting in PDAC by Francesca Citron
Wafik S. El-Deiry shared a post on X: '' Francesca Citron from MD Anderson Cancer…
Sep 1, 2024, 09:48 | Insight
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Jarushka Naidoo shared a post on X: "Phase  III Keynote-789 Trial of Platinum + Pemetrexed +/-Pembro…
Aug 27, 2024, 21:09 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 19, 2024, 08:50 | Insight
Mourning the loss of Dr. Charis Eng
Charis Eng, MD, PhD, was the Chair and founding Director of the Genomic Medicine Institute of…
Aug 19, 2024, 08:29 | Insight
4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin - IASLC
Stephen V. Liu shared a post by IASLC on X, adding: “Thanks to Drs. Chunxia…
Jul 19, 2024, 15:23 | Insight
MRD testing using a ctDNA to Predict Recurrence of Metastatic Colorectal Cancer
Arndt Vogel shared on X: "MRD testing using a ctDNA to Predict Recurrence of Metastatic…
Jun 1, 2024, 14:46 | Societies
15 Posts From ASCO24 Day 1 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 1, 2024, 10:17 | Blog
Hidehito Horinouchi: HARMONi-A - Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Apr 26, 2024, 20:26 | Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
All: 10 Posts: 1 - 100
Special Coverage